John Cunningham virus T-antigen expression in anal carcinoma

Area of Science:

• Oncology
• Virology
• Molecular Biology

Background:

• Anal carcinoma is often linked to human papillomavirus (HPV) infection.
• John Cunningham virus (JCV) T-antigen is implicated in other cancers, but its role in anal cancer is unstudied.
• JCV T-antigen disrupts cell regulatory proteins, similar to HPV.

Purpose of the Study:

• To investigate the presence and role of JCV T-antigen in anal carcinoma.
• To correlate JCV T-antigen expression with clinicopathologic features of anal cancer.

Main Methods:

• Analysis of archived anal carcinoma samples for JCV T-antigen expression.
• DNA sequencing and quantitative PCR to determine JCV viral load.
• Correlation of JCV T-antigen status with HPV and microsatellite instability (MSI).

Main Results:

• All 21 anal cancer cases expressed JCV T-antigen.
• JCV viral load was significantly higher in tumor tissue than normal tissue.
• JCV T-antigen expression was independent of HPV status, MSI, disease stage, and HIV status.

Conclusions:

• Anal carcinomas consistently express JCV T-antigen.
• Elevated JCV viral copies in tumors suggest a potential role in anal cancer pathogenesis.
• JCV T-antigen may contribute to anal cancer development by interfering with cell regulatory proteins.